trypanosoma
cruzi
flagel
protozoan
belong
trypanosomatida
famili
etiolog
agent
chaga
diseas
current
neither
licens
vaccin
effect
treatment
character
unmet
clinic
need
igi
refer
egg
yolk
immunoglobulin
yolk
product
use
subject
mani
studi
due
divers
diagnost
therapeut
applic
sever
research
shown
use
specif
igi
may
prevent
andor
control
infecti
parasit
diseas
base
evid
aim
studi
immun
chicken
trypomastigot
cruzi
order
produc
highli
effect
pure
antibodi
igi
well
extract
character
quantifi
verifi
cytotox
effect
igi
antit
cruzi
induct
igi
product
chicken
egg
collect
igi
extract
method
precipit
polyethylen
glycol
igi
antit
cruzi
character
perform
use
polyacrylamid
gel
electrophoresi
sdspage
westernblot
enzymelink
immunosorb
assay
elisa
moreov
cytotox
prolif
effect
igi
antit
cruzi
verifi
mtt
assay
concentr
igi
yolk
mgml
character
igi
revel
band
stain
peptid
molecular
weight
kda
kda
elisa
test
observ
antigenantibodi
reaction
throughout
sampl
period
concentr
mgml
igi
antit
cruzi
present
cytotox
prolif
effect
mononuclear
vero
cell
vitro
result
indic
cruzi
abl
gener
high
product
specif
immunoglobulin
chicken
caus
damag
cell
membran
prolif
effect
chaga
diseas
neglect
tropic
diseas
caus
trypanosoma
cruzi
obligatori
intracellular
parasit
wide
spread
latin
america
basso
marini
diseas
constitut
seriou
worldwid
public
health
issu
coura
dia
caus
chronic
parasit
condit
character
lifelong
infect
host
martin
et
al
clinic
diseas
may
acut
phase
last
month
character
patent
parasitemia
chronic
phase
lifelong
phase
includ
subpat
parasitemia
tissu
parasit
dia
rassi
et
al
diagnosi
cruzi
infect
acut
phase
carri
direct
detect
circul
parasit
howev
chronic
phase
diagnosi
perform
convent
serolog
assay
otani
et
al
carlier
torrico
chemic
drug
benzimidazol
nifurtimox
still
use
method
choic
control
diseas
urbina
docampo
howev
treatment
benzimidazol
mani
side
effect
prolong
treatment
time
low
variabl
efficaci
chronic
phase
infect
preval
form
diseas
urbina
docampo
viotti
et
al
thu
search
effect
medic
less
advers
effect
one
main
focus
mani
studi
coura
context
search
altern
model
treatment
diagnosi
cruzi
essenti
mainli
diseas
consid
neglect
specif
antibodi
immunotherapi
parasit
might
therapeut
altern
control
andor
prevent
infect
immunoglobulin
igi
polyclon
antibodi
obtain
egg
yolk
yolk
immun
chicken
molecul
high
specif
bind
inactiv
foreign
substanc
antigen
molecul
abl
invad
bodi
karlsson
et
al
reason
igi
use
diagnosi
therapi
reilli
et
al
igi
technolog
allow
obtain
antibodi
high
affin
avid
karlsson
et
al
addit
igi
show
numer
advantag
compar
mammalian
antibodi
similar
function
mammalian
igg
ige
cross
reaction
mammalian
igg
attack
red
blood
cell
activ
complement
system
coagul
cascad
furthermor
chicken
abl
produc
antibodi
rabbit
goat
hors
rodent
sampaio
et
al
chacana
et
al
contrera
et
al
therefor
aim
studi
synthet
extract
character
quantifi
antibodi
igi
antit
cruzi
extract
egg
yolk
chicken
immun
trypomastigot
cruzi
moreov
effect
igi
antit
cruzi
vitro
mononuclear
vero
cell
perform
order
evalu
possibl
collater
effect
procedur
studi
approv
anim
welfar
committe
ethic
anim
experiment
universidad
feder
de
santa
maria
ufsm
protocol
number
igi
product
extract
purif
antigen
trypomastigot
form
cruzi
strain
use
antigen
immun
chicken
accord
method
describ
sampaio
et
al
adapt
cruzi
follow
cryopreserv
trypomastigot
inocul
mice
reactiv
multipl
strain
blood
sampl
collect
peak
parasitemia
order
separ
parasit
blood
dilut
dmem
medium
vv
follow
centrifug
g
min
supernat
rich
trypomastigot
collect
amount
antigen
determin
aliquot
cryopreserv
use
chicken
immun
protocol
describ
sampaio
et
al
briefli
solut
contain
trypomastigot
cruzi
ad
incomplet
freund
adjuv
ratio
final
volum
ml
inject
intramuscularli
five
differ
site
pector
muscl
two
new
hampshir
chicken
interv
immun
set
day
day
total
eight
inocul
trypomastigot
first
inocul
trypomastigot
cruzi
inocul
chicken
egg
collect
third
week
postimmun
store
process
one
chicken
immun
egg
use
control
extract
perform
method
precipit
polyethylen
glycol
polson
et
al
firstli
yolk
gentli
separ
fat
remov
use
pb
ratio
peg
final
concentr
mixtur
held
roller
mix
min
centrifug
min
rpm
supernat
remov
filter
filter
paper
final
volum
measur
peg
ad
solut
kept
roller
mix
min
centrifug
min
rpm
stage
supernat
discard
pellet
dissolv
ml
pb
final
step
use
peg
perform
describ
previous
final
pellet
dissolv
ml
pb
solut
dialyz
overnight
salin
solut
final
dialyz
perform
three
hour
extract
collect
place
tube
store
lyophil
use
specif
concentr
igi
antit
cruzi
measur
accord
lambertb
law
use
extinct
coeffici
igi
polson
et
al
protein
content
sampl
measur
method
bradford
coomassi
blue
use
bovin
serum
albumin
standard
monitor
measur
maximum
absorb
solut
nm
igi
character
evalu
regard
specif
sensibl
antigen
follow
igi
sampl
analyz
sodium
dodecyl
sulfatepolyacrylamid
gel
electrophoresi
sdspage
bernardo
igi
sampl
collect
chicken
week
postimmun
control
sampl
nonimmun
chicken
mix
buffer
laemmli
sampl
buffer
boil
water
bath
min
appli
stack
gel
well
final
volum
electrophoresi
submit
current
v
min
v
min
final
gel
color
coomassi
blue
r
least
h
treat
decolor
solut
glacial
acet
acid
methanol
western
blot
perform
describ
bernardo
initi
electrophoresi
perform
condit
describ
two
gel
prepar
one
igi
sampl
use
section
second
gel
sampl
antigen
use
immun
chicken
trypomastigot
cruzi
sampl
trypomastigot
trypanosoma
evansi
protein
separ
polyacrylamid
gel
electrophoret
transfer
nitrocellulos
membran
biorad
use
current
v
min
final
membran
remov
care
block
overnight
pbstween
solut
skim
milk
powder
membran
contain
igi
wash
three
time
pbstween
incub
h
rabbit
antichicken
igi
peroxidas
conjug
dilut
pbstween
nitrocellulos
membran
contain
antigen
evansi
cruzi
wash
three
time
pbstween
incub
one
hour
newli
synthet
igi
antit
cruzi
primari
antibodi
control
igi
membran
wash
three
time
pbstween
incub
one
hour
rabbit
antichicken
antibodi
peroxidas
conjug
membran
wash
three
time
pbstween
final
incub
develop
solut
dabdiaminobenzidin
tri
hcl
nickel
sulfat
h
visual
reactiv
band
enzym
link
immun
sorbent
assay
elisa
perform
describ
sampaio
et
al
elisa
plate
coat
cruzi
antigen
previous
dilut
carbon
buffer
ph
plate
incub
overnight
incub
plate
wash
four
time
salin
buffer
sb
ph
firstli
block
fetal
bovin
serum
fb
sp
brazil
sb
fb
per
well
incub
plate
wash
four
time
sbtween
sb
ph
tween
igi
sampl
extract
differ
week
postimmun
dilut
fb
sb
distribut
plate
incub
h
plate
wash
four
time
sampl
test
submit
three
repetit
per
plate
two
repetit
interpl
incub
igi
primari
antibodi
plate
wash
four
time
sbstween
submit
incub
secondari
antibodi
rabbit
antichicken
igi
peroxidas
conjug
dilut
h
final
plate
wash
chromogen
substrat
orthophenylenediamin
opd
ad
min
reaction
block
h
read
perform
nm
use
spectrophotomet
order
evalu
whether
igi
may
caus
cytotox
effect
use
mtt
assay
two
cell
line
peripher
blood
mononuclear
cell
nonadher
cell
vero
cell
adher
cell
sampl
peripher
blood
suppli
clinic
analysi
laboratori
franciscan
univers
center
project
approv
research
ethic
committe
franciscan
univers
center
caae
peripher
blood
sampl
collect
venipunctur
use
top
bd
diagnost
plymouth
uk
heparin
tube
sampl
drawn
h
overnight
fast
three
appar
healthi
human
volunt
year
old
nonsmok
take
prescript
drug
drink
habit
two
alcohol
beverag
week
lymphocyt
cell
separ
sigmaaldrich
co
st
loui
usa
densiti
gradient
centrifug
use
ml
blood
sampl
centrifug
min
cell
transfer
cultur
media
contain
ml
rpmi
supplement
fb
penicillin
streptomycin
cell
cultur
micropl
initi
densiti
h
humidifi
co
atmospher
wilm
et
al
green
monkey
kidney
vero
cell
adolpho
lutz
institut
paulo
brazil
passag
cultur
plate
corn
usa
emem
supplement
vv
fb
gibco
brl
vv
lglutamin
mmol
l
mgml
ciprofloxacin
baytril
bayer
gml
amphotericin
b
gibco
brl
cell
maintain
humidifi
incub
co
atmospher
cytotox
igi
lymphocyt
nonadher
vero
cell
adher
evalu
describ
sagrillo
et
al
use
mtt
tetrazolium
bromid
colorimetr
method
base
cleavag
reagent
dehydrogenas
viabl
cell
mosman
micropl
cell
incub
humid
atmospher
co
h
end
incub
mtt
solut
ad
well
cell
incub
three
hour
supernat
remov
dimethyl
sulfoxid
dmso
ad
well
micropl
analyz
use
elisa
reader
wavelength
nm
control
cell
grown
medium
lack
constitu
experi
perform
triplic
treatment
use
concentr
mgml
igi
antit
cruzi
final
cell
viabil
determin
express
percentag
control
valu
normal
homoscedast
analyz
shapirowilk
leven
test
respect
signific
differ
group
analyz
detect
twoway
analys
varianc
anova
independ
sampl
follow
tukey
posthoc
test
differ
consid
statist
signific
p
b
product
igi
immun
chicken
observ
studi
period
averag
concentr
igi
antibodi
purifi
week
immun
mgml
polyacrylamid
gel
show
band
stain
peptid
molecular
weight
kda
igi
heavi
chain
kda
igi
light
chain
fig
find
obtain
sampl
demonstr
extract
protocol
effect
separ
igi
result
first
western
blot
igi
control
sampl
igi
immun
chicken
week
immun
seen
fig
figur
show
band
molecular
weight
kda
band
kda
correspond
heavi
light
chain
igi
demonstr
band
found
electrophoresi
gel
molecular
weight
refer
igi
second
membran
electrophoret
transfer
fig
antigen
sampl
show
igi
newli
synthet
antit
cruzi
react
protein
speci
trypanosoma
cruzi
evansi
indic
crossreact
immunoglobulin
produc
abl
recogn
cruzi
sever
protein
homolog
protein
evansi
also
recogn
demonstr
igi
anti
cruzi
provid
crossreact
trypanosomatid
use
test
diagnos
specif
also
result
igi
control
neg
indic
igi
produc
specif
target
antigen
posit
result
obtain
dilut
test
antigenantibodi
reaction
optic
densiti
od
fig
also
observ
decreas
antigenantibodi
reaction
week
refer
reduct
trypomastigot
concentr
antigen
use
immun
chicken
thu
indic
reduct
specif
igi
antit
cruzi
product
order
determin
whether
igi
led
increas
cellular
toxic
mtt
assay
cell
viabil
use
shown
fig
igi
caus
cytotox
effect
concentr
mgml
h
postincub
pbmc
vero
cell
cultur
p
n
identif
altern
treatment
effici
less
toxic
cruzi
necessari
sinc
sever
resist
toxic
effect
report
use
convent
drug
viotti
et
al
therefor
therapeut
immunizationimmunotherapi
use
cruzi
antigen
also
use
control
infect
reduc
diseas
progress
result
demonstr
possibl
produc
igi
inocul
trypomastigot
form
cruzi
chicken
egg
yolk
method
immun
recommend
sampaio
et
al
demonstr
effect
easi
method
implement
product
igi
antit
cruzi
result
show
product
igi
inocul
trypomastigot
cruzi
produc
averag
mgml
igi
wherea
trypomastigot
evansi
produc
averag
mgml
sampaio
et
al
differ
might
relat
immun
protocol
sinc
use
day
interv
moreov
differ
may
occur
due
greater
immun
respons
mount
chicken
opposit
antigen
epitop
cruzi
antigen
epitop
may
complex
evansi
addit
regard
elisa
result
higher
optic
densiti
observ
week
coincid
inocul
greater
number
trypomastigot
trypomastigotesml
show
antigen
concentr
close
relat
specif
product
igi
furthermor
major
reduct
igi
activ
due
reduct
immun
respons
anim
antigen
sinc
sever
inocul
antigen
seen
challeng
anymor
kda
arrow
indic
interv
band
kda
refer
heavi
chain
kda
refer
light
chain
igi
produc
week
postimmun
band
kda
arrow
indic
band
kda
demonstr
rang
igi
heavi
light
chain
band
igi
produc
week
postimmun
control
igi
b
immunoblot
show
specif
recognit
igi
antit
cruzi
igi
control
protein
antigen
cruzi
evansi
sampl
addit
peroxidaseconjug
secondari
antibodi
current
sever
method
isol
purifi
function
activ
chicken
igi
egg
yolk
even
larg
scale
purif
munhoz
et
al
method
perform
salt
precipit
deignan
et
al
chacana
et
al
chromatograph
techniqu
meulena
huyghebaert
ultrafiltr
kim
nakai
choos
use
salt
precipit
method
use
describ
polson
et
al
sinc
easi
perform
techniqu
wide
describ
literatur
effect
highyield
antibodi
besid
advantag
possibl
handl
room
temperatur
without
risk
denatur
immunoglobulin
akita
nakai
specif
character
antit
cruzi
igi
confirm
polyacrylamid
electrophoresi
gel
western
blot
molecular
weight
kda
heavi
chain
light
chain
found
studi
similar
describ
contrera
et
al
avian
antibodi
produc
intraderm
immun
chicken
cruzi
epimastigot
howev
literatur
report
light
chain
igi
weight
kda
sun
et
al
kda
hatta
et
al
differ
result
molecular
weight
character
differ
igi
igi
antistaphylococcu
aureu
light
chain
kda
heavi
chain
kda
reddi
et
al
igi
antischistosoma
japonicum
light
heavi
chain
kda
respect
cai
et
al
demonstr
certain
variabl
molecular
weight
igi
produc
igi
technolog
use
mani
medic
area
especi
diagnosi
purpos
specif
chicken
antibodi
success
use
wide
varieti
antigen
munhoz
et
al
variou
author
report
effici
sensit
specif
diagnost
test
use
igi
variou
microorgan
toxoplasma
gondii
schistosoma
japonicum
trichinella
spirali
coronaviru
ferreira
et
al
cai
et
al
wang
et
al
palaniyappan
et
al
result
experi
regard
igi
antit
cruzi
indic
antibodi
could
use
diagnost
test
sinc
show
crossreact
antigen
evansi
hand
find
leav
possibl
igi
could
use
immunotherapi
mani
trypanosom
mtt
assay
wide
use
evalu
cell
viabil
well
level
mitochondri
metabol
activ
viabl
cell
high
degre
accuraci
mosman
present
studi
igi
fig
optic
densiti
valu
obtain
elisa
use
purifi
igi
egg
yolk
immun
chicken
sampl
test
igi
extract
differ
week
immun
differ
concentr
arrow
indic
time
last
immun
concentr
mgml
abl
maintain
cell
viabil
exposur
time
test
use
pbmc
vero
cell
caus
damag
dna
result
similar
found
sampaio
et
al
use
igi
antit
evansi
pbmc
cell
concentr
mgml
import
blood
protozoan
belong
trypanosomatida
famili
thu
conclud
concentr
igi
may
consid
safe
cell
result
indic
cruzi
abl
gener
humor
immun
respons
chicken
result
synthesi
high
specif
immunoglobulin
cruzi
caus
damag
cell
membran
well
prolif
effect
mononuclear
vero
cell
cultur
